Comparing Zeltiq Aesthetics (ZLTQ) & Its Competitors
Zeltiq Aesthetics (NASDAQ: ZLTQ) is one of 85 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it compare to its rivals? We will compare Zeltiq Aesthetics to similar businesses based on the strength of its risk, analyst recommendations, valuation, earnings, dividends, institutional ownership and profitability.
This is a summary of recent ratings and target prices for Zeltiq Aesthetics and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Zeltiq Aesthetics Competitors||267||1869||3359||108||2.59|
Zeltiq Aesthetics presently has a consensus target price of $56.83, suggesting a potential upside of Infinity. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 7.54%. Given Zeltiq Aesthetics’ higher probable upside, research analysts plainly believe Zeltiq Aesthetics is more favorable than its rivals.
Earnings & Valuation
This table compares Zeltiq Aesthetics and its rivals gross revenue, earnings per share and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Zeltiq Aesthetics Competitors||$2.17 billion||$225.99 million||-11.47|
Zeltiq Aesthetics’ rivals have higher revenue and earnings than Zeltiq Aesthetics. Zeltiq Aesthetics is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Institutional and Insider Ownership
52.0% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 15.6% of Zeltiq Aesthetics shares are held by company insiders. Comparatively, 18.9% of shares of all “Advanced Medical Equipment & Technology” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
This table compares Zeltiq Aesthetics and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Zeltiq Aesthetics Competitors||-293.22%||-31.89%||-10.28%|
Zeltiq Aesthetics rivals beat Zeltiq Aesthetics on 6 of the 10 factors compared.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.
Receive News & Stock Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related stocks with our FREE daily email newsletter.